Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    May 2019
  1. PUCHULU MB, Arreche N, Zotta E, Donato M, et al
    Erythropoietin Improves Cardiovascular Function in Adult Rats After Acute Hemorrhage.
    J Cardiovasc Pharmacol. 2019;73:290-300.
    PubMed     Text format     Abstract available


  2. CHEN W, Chen XY, Wang Y, Wang HY, et al
    Mechanism of Emulsified Isoflurane Postconditioning-Induced Activation of the Nrf2-Antioxidant Response Element Signaling Pathway During Myocardial Ischemia-Reperfusion: The Relationship With Reactive Oxygen Species.
    J Cardiovasc Pharmacol. 2019;73:265-271.
    PubMed     Text format     Abstract available


    March 2019
  3. SALAH E, Bastacky SI, Jackson EK, Tofovic SP, et al
    2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    J Cardiovasc Pharmacol. 2019;73:165-177.
    PubMed     Text format     Abstract available


    December 2018
  4. MOMCILOVIC S, Milovanovic JR, Jankovic SM, Jovanovic A, et al
    Population pharmacokinetic analysis of bisoprolol in patients with acute coronary syndrome.
    J Cardiovasc Pharmacol. 2018 Dec 10. doi: 10.1097/FJC.0000000000000644.
    PubMed     Text format     Abstract available


    November 2018
  5. LEENEN FH, Ahmad M, Marc Y, Llorens-Cortes C, et al
    Specific Inhibition of Brain Angiotensin III formation as a new strategy for prevention of heart failure after myocardial infarction.
    J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000638.
    PubMed     Text format     Abstract available


  6. LIU XW, Lu MK, Zhong HT, Wang LH, et al
    Panax Notoginseng Saponins Attenuate Myocardial Ischemia Reperfusion Injury via the HIF-1alpha/BNIP3 Pathway of Autophagy.
    J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000640.
    PubMed     Text format     Abstract available


  7. TIAN X, Zhou Y, Wang Y, Zhang S, et al
    Mitochondrial Dysfunction and Apoptosis are Attenuated upon kappa-Opioid Receptor Activation via AMPK/GSK-3beta Pathway Following Myocardial Ischemia and Reperfusion.
    J Cardiovasc Pharmacol. 2018 Nov 5. doi: 10.1097/FJC.0000000000000635.
    PubMed     Text format     Abstract available


    October 2018
  8. BOOZ GW
    Seizing the Future: What's next for the Journal of Cardiovascular Pharmacology?
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000630.
    PubMed     Text format    


  9. PIQUERAS-FLORES J, Jurado-Roman A, Lopez-Lluva MT, Sanchez-Perez I, et al
    Efficacy and safety of loading doses with P2Y12-receptor antagonists in patients without dual antiplatelet therapy undergoing elective coronary intervention.
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000632.
    PubMed     Text format     Abstract available


  10. YUAN L, Tang C, Li D, Yang Z, et al
    microRNA-18a expression in female coronary heart disease and regulatory mechanism on endothelial cell by targeting estrogen receptorsss.
    J Cardiovasc Pharmacol. 2018 Oct 24. doi: 10.1097/FJC.0000000000000623.
    PubMed     Text format     Abstract available


    June 2018
  11. DIMITROULIS D, Golabkesh M, Naguib D, Knoop B, et al
    Safety and efficacy in Prasugrel vs. Ticagrelor treated ST-elevation myocardial infarction (STEMI) patients.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000609.
    PubMed     Text format     Abstract available


  12. ZHOU L, Liu X, Wang ZQ, Li Y, et al
    Simvastatin Treatment Protects Myocardium in Non-coronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000611.
    PubMed     Text format     Abstract available


    May 2018
  13. VAN TAUNAY JS, Albelda MT, Frias JC, Lipinski MJ, et al
    Biologics and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000595.
    PubMed     Text format     Abstract available


    April 2018
  14. CHEN S, Zhang S, Luan H, Zeng X, et al
    Correlation Between Extended Leukocyte Differential Count and Coronary Artery Disease.
    J Cardiovasc Pharmacol. 2018 Apr 10. doi: 10.1097/FJC.0000000000000582.
    PubMed     Text format     Abstract available


  15. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
    Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    J Cardiovasc Pharmacol. 2018;71:205-214.
    PubMed     Text format     Abstract available


    March 2018
  16. ABOUZAKI NA, Christopher S, Trankle C, Van Tassell BW, et al
    Inhibiting the inflammatory injury following myocardial ischemia reperfusion with plasma derived alpha-1 anti-trypsin: a post-hoc analysis of the VCU-alpha1RT study.
    J Cardiovasc Pharmacol. 2018 Mar 23. doi: 10.1097/FJC.0000000000000583.
    PubMed     Text format     Abstract available


  17. BISGAIER CL, Oniciu DC, Srivastava RAK
    Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 Mar 21. doi: 10.1097/FJC.0000000000000580.
    PubMed     Text format     Abstract available


  18. MOHAMMAD FIC AM, Al-Allawi NA
    CYP2C19 genotype is an independent predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel Post Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2018 Mar 12. doi: 10.1097/FJC.0000000000000577.
    PubMed     Text format     Abstract available


  19. DARWESH AM, El-Azab MF, Abo-Gresha NM, El-Sayed NM, et al
    Cardioprotective Mechanisms of Exenatide in Isoprenaline-induced Myocardial Infarction: Novel Effects on Myocardial alpha-Estrogen Receptor Expression and IGF-1/IGF-2 System.
    J Cardiovasc Pharmacol. 2018;71:160-173.
    PubMed     Text format     Abstract available


    February 2018
  20. DUAN Q, Xu Y, Marck PV, Kalisz J, et al
    Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart.
    J Cardiovasc Pharmacol. 2018;71:95-103.
    PubMed     Text format     Abstract available


    January 2018
  21. SIGURDSSON MI, Waldron NH, Bortsov AV, Smith SB, et al
    Genomics of Cardiovascular Measures of Autonomic Tone.
    J Cardiovasc Pharmacol. 2018 Jan 3. doi: 10.1097/FJC.0000000000000559.
    PubMed     Text format     Abstract available


    December 2017
  22. ABBATE A
    Why the CANTOS Is a Game Changer in Cardiovascular Medicine.
    J Cardiovasc Pharmacol. 2017;70:353-355.
    PubMed     Text format    


    September 2017
  23. JAZMIN FM, Diana RH, Citali SH, Diego LM, et al
    Sex Differences In Vascular Reactivity To Angiotensin Ii During The Evolution Of Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Sep 29. doi: 10.1097/FJC.0000000000000542.
    PubMed     Text format     Abstract available


    June 2017
  24. ZHONG Y, Zhong P, He S, Zhang Y, et al
    Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
    J Cardiovasc Pharmacol. 2017;69:389-397.
    PubMed     Text format     Abstract available


    May 2017
  25. HARISSEH R, Chiari P, Villedieu C, Sueur P, et al
    Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane.
    J Cardiovasc Pharmacol. 2017;69:326-334.
    PubMed     Text format     Abstract available


  26. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Text format     Abstract available


    April 2017
  27. BEHMENBURG F, Pickert E, Mathes A, Heinen A, et al
    The Cardioprotective Effect of Dexmedetomidine in Rats Is Dose-Dependent and Mediated by BKCa Channels.
    J Cardiovasc Pharmacol. 2017;69:228-235.
    PubMed     Text format     Abstract available


    March 2017
  28. ZHU A, Wei X, Zhang Y, You T, et al
    Propofol Provides Cardiac Protection by Suppressing the Proteasome Degradation of Caveolin-3 in Ischemic/Reperfused Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:170-177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: